Clinical and Pathologic Spectrum of<i>DDX41-</i>Mutated Hematolymphoid Neoplasms

Abstract

This report extends the spectrum of DDX41-mutated disorders to include CCUS, T-LGL, and plasma cell disorders. The morphologic features are heterogeneous and nonspecific, highlighting the importance of DDX41 testing during routine workup of hematolymphoid neoplasms.